Pushing the boundaries of science in critical disciplines

April's Story

The personalized journey

James Watson, Francis Crick, Maurice Wilkins, and Rosalind Franklin determined the structure of DNA in 1953, ushering in a new understanding of heredity and its implication in disease. Today, semiconductor sequencing is transforming cancer research through the routine identification of mutations. As the era of personalized medicine approaches, the potential for clinically relevant genetic variants to impact an individual’s health becomes paramount.

Getting personal in the fight against breast cancer

Technologies such as digital PCR are accelerating our journey to realizing personalized medicine. Filling the quantitative gap left by traditional qPCR techniques, digital PCR can provide the sensitivity of detection needed to discover unique mutations that have eluded detection via other techniques. This is enabling great strides to be made in the area of cancer research, particularly breast cancer, and is fueling the movement towards more targeted, gene-based strategies.

Featured technology: Digital PCR

The QuantStudio™ 3D Digital PCR System was used in research on HER2, a gene associated with breast cancer. Discover the new generation of PCR >


Research milestone:

Using the QuantStudio™ 3D Digital PCR System. Bruno Ping of the Royal Surrey County Hospital in Guildford, United Kingdom, leveraged the power of digital PCR in his research on HER2, a gene associated with breast cancer. Read about his innovative research >

Century of Amazing Science Video

We are living in the century of amazing science. Never before have scientists been so empowered with access to advanced technology and global connectedness, encouraging boundless science in critical disciplines like health, food, environment and energy.

It's your time to effect exponential change in the world. And it's our promise to empower you with innovations that help you do it faster.

Let us put these valuable resources directly into your hands